Bg pattern

LUBRISTESIC 7.5 mg/g OINTMENT

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use LUBRISTESIC 7.5 mg/g OINTMENT

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Package Leaflet: Information for the User

Lubristesic 7.5 mg/g Urethral Ointment

Tetracaine Hydrochloride

Read all of this leaflet carefully before you start using this medicine because it contains important information for you.

  • Keep this leaflet, you may need to read it again.
  • If you have any further questions, ask your doctor, pharmacist, or nurse.
  • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
  • If you get any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in this leaflet. See section 4.

Contents of the Package Leaflet

  1. What is Lubristesic 7.5 mg/g Urethral Ointment and what is it used for
  2. What you need to know before you start using Lubristesic 7.5 mg/g Urethral Ointment
  3. How to use Lubristesic 7.5 mg/g Urethral Ointment
  4. Possible side effects
  5. Storage of Lubristesic 7.5 mg/g Urethral Ointment
  6. Contents of the pack and further information

1. What is Lubristesic 7.5 mg/g Urethral Ointment and what is it used for

This medicine contains tetracaine, an active substance belonging to the group of local anesthetics.

Lubristesic is a urethral ointment, lubricating and anesthetic for local use, used for catheterizations in general, cystoscopies, urethroscopies, urethral sounding, etc.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before you start using Lubristesic 7.5 mg/g Urethral Ointment

Do not use Lubristesic 7.5 mg/g Urethral Ointment:

  • if you are allergic to tetracaine or any of the other components of this medicine (listed in section 6).
  • if you are allergic to other local anesthetics of the ester type.
  • on lacerated or wounded skin or mucous membranes.
  • in children under 1 month or in premature babies due to the lack of maturity of the enzymatic system that metabolizes local anesthetics of the ester type.
  • in conjunction with other topical products.

Warnings and precautions

Consult your doctor, pharmacist, or nurse before starting to use Lubristesic.

It must not be ingested.

The topical or local injectable administration of anesthetics such as benzocaine and prilocaine, more commonly, or after the administration of lidocaine, procaine, and tetracaine, may produce methemoglobinemia. Methemoglobinemia can be the result of administering normal doses as well as exposure to toxic concentrations of local anesthetics.

It is not recommended to apply this medicine to the middle ear or in procedures that could involve penetration of the middle ear.

Repeated application of Lubristesic could increase the risk of allergic reactions to tetracaine.

Children

This medicine is not recommended for use in children under 1 month or in premature babies.

Other medicines and Lubristesic 7.5 mg/g Urethral Ointment

Tell your doctor or pharmacist if you are using, have recently used, or might use any other medicines.

Lubristesic administered with the following medicines may affect the kinetics of tetracaine, for example:

  • antibiotic medicines of the sulfonamide type, may decrease their activity.
  • cholinesterase inhibitor medicines such as: demecarium (medicine used to treat glaucoma), cyclophosphamide (medicine for cancer treatment), echothiophate (medicine for cancer treatment), and thiotepa (medicine for cancer treatment), may increase the risk of systemic toxicity (in the body).
  • medicines known to induce methemoglobinemia such as: furanides (antibiotics), nitrates and nitrites (treatment of angina pectoris), nitrofurantoin (antibiotic), nitroglycerin (preventive treatment of angina pectoris), nitroprusside (medicine to reduce blood pressure), pamaquine, and quinine (for malaria treatment), and naphthalene.

In case of doubt, consult your doctor or pharmacist.

Pregnancy, breastfeeding, and fertility

If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before using this medicine.

In case of pregnancy or breastfeeding, your doctor will decide whether to use this medicine.

Driving and using machines

The influence of this medicine on the ability to drive and use machines is zero or insignificant.

Lubristesic contains methylparaben

It may cause allergic reactions (possibly delayed) because it contains methylparaben.

3. How to use Lubristesic 7.5 mg/g Urethral Ointment

Follow exactly the administration instructions of this medicine indicated by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.

Lubristesic is exclusively for urethral use. It must not be ingested.

Adults (including elderly patients) and children over 1 month:

Your doctor will determine the most suitable dose for you and the duration of treatment according to the application and at the doctor's discretion.

If you use more Lubristesic 7.5 mg/g Urethral Ointment than you should

It is unlikely that this will happen since your doctor will be in charge of defining the most suitable dose for you. In case you are administered more doses than due, your doctor will take the necessary measures to restore your state.

In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or go to a medical center, or call the Toxicology Information Service, tel.: 91 562 04 20, indicating the medicine and the amount ingested.

If you have any other questions about the use of this medicine, ask your doctor, pharmacist, or nurse.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

Uncommon side effects: may affect up to 1 in 100 people

  • Mild redness or itching at the application site

Rare side effects: may affect up to 1 in 1,000 people

  • More severe redness or itching at the application site

Very rare side effects: may affect up to 1 in 10,000 people

  • Blisters on the skin at the application site.
  • Allergic contact dermatitis.
  • Systemic contact eczema.

Some allergic or anaphylactoid reactions associated with tetracaine may occur.

Reporting of side effects

If you experience any side effects, talk to your doctor, pharmacist, or nurse, even if it is possible side effects not listed in this leaflet. You can also report them directly through the Medicines and Healthcare products Regulatory Agency (MHRA) https://www.mhra.gov.uk/. By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storage of Lubristesic 7.5 mg/g Urethral Ointment

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the packaging after EXP. The expiry date is the last day of the month shown.

No special storage conditions are required.

Store in the original packaging.

Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.

6. Contents of the pack and further information

Composition of Lubristesic 7.5 mg/g Urethral Ointment

  • The active substance is tetracaine hydrochloride.
  • Each gram of urethral ointment contains 7.5 mg of tetracaine hydrochloride.
  • The other components (excipients) are: glycerol (E-422), cornstarch, tragacanth gum, methylparaben (E-219), ethanol 96%, and purified water.

Appearance and packaging of the product

Lubristesic 7.5 mg/g Urethral Ointment is a urethral ointment, white in color, homogeneous, smooth, and free from visible impurities.

Lubristesic 7.5 mg/g Urethral Ointment is presented in a low-density polyethylene tube containing 8 or 25 grams of urethral ointment.

Lubristesic 7.5 mg/g Urethral Ointment is presented in a single unit pack containing 25 grams of ointment and in a clinical pack containing 200 units, with 8 grams of urethral ointment.

Marketing authorization holder and manufacturer

Marketing authorization holder

Galenicum Derma S.L.U.

Ctra N-1, Km 36

28750 San Agustin del Guadalix (Madrid)

Spain

Manufacturer

SAG Manufacturing, S.L.U.

Carretera N-I, km 36

28750 San Agustín del Guadalix

Madrid – Spain

Date of last revision of this leaflet: September 2019

Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/

Online doctors for LUBRISTESIC 7.5 mg/g OINTMENT

Discuss questions about LUBRISTESIC 7.5 mg/g OINTMENT, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (5)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques. For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance. Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults. In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions. Patients commonly seek his care for: 

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns

Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.

Camera Book a video appointment
€86
0.0 (0)
Doctor

Joao Silva

General medicine 6 years exp.

Dr. João Silva is a physician with training and experience in the field of General and Family Medicine, dedicated to providing healthcare focused on the well-being and quality of life of his patients. Throughout his professional career, he has developed broad clinical competencies, striving to maintain a medical practice based on scientific evidence and continuous knowledge updates.

Between 2013 and 2019, he completed the Integrated Master's Degree in Medicine at the Abel Salazar Institute of Biomedical Sciences in Porto, where he acquired a solid academic and clinical education.

Subsequently, between January 2021 and December 2021, he completed the General Internship at the Entre Douro e Vouga Hospital Center in Santa Maria da Feira, where he had the opportunity to work in different hospital settings and deepen his competencies in several areas of medicine.

From January 2022 until March 2026, he works as a Resident Physician in General and Family Medicine at USF Salvador Machado in Oliveira de Azeméis, developing clinical activities in primary healthcare, follow-up of chronic patients, and health promotion in the community.

Complementing his medical training, Dr. João Silva also completed a Postgraduate Degree in Continuing and Palliative Care at CESPU, strengthening his preparation in the comprehensive approach to patient care, especially in situations requiring prolonged care and multidisciplinary support.

Camera Book a video appointment
€61

Get LUBRISTESIC 7.5 mg/g OINTMENT Prescription Online

1

Fill in a 2-min form

Tell us your symptoms, history, and what medicine you're requesting.

2

Pick a doctor or let us assign

Choose a specialist or we'll match you with the next available doctor.

3

Doctor reviews your case

Usually within 30 minutes. They may ask follow-up questions via chat.

4

Collect from any pharmacy

Electronic prescription sent to your email — valid across Spain.

Frequently Asked Questions

Is a prescription required for LUBRISTESIC 7.5 mg/g OINTMENT?

LUBRISTESIC 7.5 mg/g OINTMENT requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.

What is the active substance in LUBRISTESIC 7.5 mg/g OINTMENT?

The active ingredient in LUBRISTESIC 7.5 mg/g OINTMENT is tetracaine. This information helps identify medicines with the same composition but different brand names.

Who manufactures LUBRISTESIC 7.5 mg/g OINTMENT?

LUBRISTESIC 7.5 mg/g OINTMENT is manufactured by Galenicum Derma S.L.U.. Pharmacy brands and packaging may differ depending on the distributor.

Which doctors can assess the use of LUBRISTESIC 7.5 mg/g OINTMENT online?

Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether LUBRISTESIC 7.5 mg/g OINTMENT is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.

How to buy LUBRISTESIC 7.5 mg/g OINTMENT in Spain?

Spain has a well-developed healthcare infrastructure across major cities such as Madrid, Barcelona, Valencia, and Seville. Pharmacies are widely available and operate under strict regulations, ensuring access to prescribed medications.

You can buy LUBRISTESIC 7.5 mg/g OINTMENT in Madrid, Barcelona, Seville, or Valencia at any local pharmacy with a valid prescription.

To obtain a prescription, you can use Oladoctor:

What are the alternatives to LUBRISTESIC 7.5 mg/g OINTMENT?

Other medicines with the same active substance (tetracaine) include TETRACAINE LAINCO 7.5 mg/g GEL, AMPRES 10 mg/ml INJECTABLE SOLUTION, AMPRES 20 mg/ml INJECTABLE SOLUTION. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.

bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media